Lux Health Tech Acquisition Corp.
Lux Health Tech Acquisition Corp. (LUXA) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
luxa · pe ratio · data through Jun 9, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Shell Companies · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Lux Health Tech Acquisition Corp.You LUXA | — | N/A | — | — |
 Alliance Entertainment Holding Corporation AENT | $278M | 12.71x | -59.6% | $0.30 |
 Arctos NorthStar Acquisition Corp. ANAC | $419M | 47.20x | +50.2% | $0.21 |
 Churchill Capital Corp VI CCVI | $433M | 23.62x | -24.9% | $0.42 |
 Lead Edge Growth Opportunities, Ltd LEGA | $441M | 38.70x | +23.1% | $0.25 |
 Motive Capital Corp II MTVC | $448M | 45.05x | +43.3% | $0.23 |
 Pivotal Investment Corporation III PICC | $89M | 21.32x | -32.2% | $0.47 |
Industry Average 6 peers with valid PE | — | 31.43x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Lux Health Tech Acquisition Corp. (LUXA) measures how much investors pay for each dollar of the company's trailing earnings. LUXA's current PE ratio of N/A is calculated by dividing its stock price of $10.05 by its TTM earnings per share of —.
Frequently asked questions
LUXA pe ratio · 6 questionsLUXA's current PE ratio is N/A as of 2026-06-09, based on a stock price of $10.05 and TTM EPS of —. Data sourced from Financial Modeling Prep via LUXA's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Lux Health Tech Acquisition Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09